Related Experiment Video
Updated: Apr 27, 2026

Mining Spatial Transcriptomics Datasets using DeepSpaceDB
Published on: September 5, 2025
Translating brain anatomy and disease from mouse to human in latent gene expression space
Chloe Jaroszynski1, Mohammed Amer2, Antoine Beauchamp3
1Oxford University Centre for Integrative Neuroimaging, Centre for Functional MRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Background:
The mouse model is the most widely used animal model in neuroscience, yet translating findings to humans suffers from the lack of formal models comparing the mouse and the human brain. Here, we devised a framework using mouse and human gene expression to build a quantitative common space and apply it to models of neurodegenerative disease.
Methods:
We trained a variational autoencoder on mouse spatial transcriptomics, and embedded mouse and human gene orthologs in the model's latent space. We computed a latent cross-species similarity matrix for translation and compared translated maps to human ground truth evidence.
Findings:
We established the validity of our model based on anatomical homology. Independent of species, brain areas with similar latent patterns clustered together, improving the homology of known anatomical pairs, and preserving principles of brain organisation. Importantly, translating brain alterations in mouse disease models predicted human patterns of brain changes in Alzheimer's and Parkinson's diseases. We further determined the best mouse model for the AD patients, based on how well the translations matched the patient data, across multiple models and timepoints.
Interpretation:
Our work provides i) a quantitative bridge across evolutionary divergence between the human and the predominant preclinical species, ii) a predictive framework to help design and evaluate disease models. By highlighting which models are best suited across stages of disease, we effectively support the understanding of disease mechanisms, assist in the workflow of clinical trials, and ultimately accelerate the transformation of findings into improved human outcomes.
Funding:
Supported by the Biotechnology and Biological Sciences Research Council (BBSRC) UK, the Medical Research Council (MRC) UK, the European Research Council, and the NIHR Oxford Health Biomedical Research Centre.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
09:35A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017